- Participants who are known to be HCV/Human Immunodeficiency Virus (HIV) co-infected may enroll if they have a positive test result for anti-HIV antibody at Screening and are: naïve to treatment with any antiretroviral therapy (ART), or on a stable, qualifying HIV ART regimen for at least 8 weeks prior to Baseline.